The Healthcare Edge — March 8, 2026

The federal panel that determines which preventive screenings Americans should get hasn't met in a year — and HHS just postponed its third consecutive session. The USPSTF March meeting was scrapped, freezing updates to cancer screening ages, STI testing intervals, and coverage recommendations that directly drive reimbursement. NIH has shed 4,400 employees — over 20% of its workforce — with cancer immunotherapy pioneers and genomics scientists walking out. FDA vaccines chief Vinay Prasad is leaving again: appointed CBER director May 2025, fired July, rehired August, departing end of April. CDER cycled through five directors in 2025 alone. The evidence pipeline that underpins clinical guidelines, drug approvals, and preventive care coverage is being dismantled in real time — and every practice relying on USPSTF recommendations for screening protocols is operating on stale guidance.

States are filling the vacuum. New Mexico's governor signed sweeping healthcare reform on March 6: tiered malpractice caps ($1M for independent providers, $6M for local hospitals, $15M for large systems), a ban on facility fees for preventive outpatient care and telehealth, and permanent Medicaid hospital funding. The malpractice bill passed 66-3 in the House and 40-2 in the Senate. Near-unanimous bipartisan support signals other states will follow. For multistate practice operators: your compliance architecture just got more complex, but the facility fee ban on preventive and telehealth visits is a template heading to a statehouse near you.

The labor crisis is boiling over. 650 physicians, PAs, and NPs at Allina Health authorized an open-ended strike across 57 clinics in Minnesota and Wisconsin — 90% voting yes after two years and 50+ bargaining sessions failed to produce a first contract. 41.5% of nurses cite burnout as their reason for leaving, nearly 40% plan to exit within five years, and replacing one costs $61,110 and 86 days. When primary care providers are striking and nurses are quitting, every staffing model in every practice is built on a foundation that's cracking.

Private capital is moving in the opposite direction of government — deploying at scale while oversight retreats. Blackstone and TPG are taking Hologic private for up to $18.3 billion, a 46% premium, in the decade's largest medtech LBO — expected to close first half of 2026. Servier is acquiring Day One Biopharmaceuticals for $2.5 billion (68% premium) to build its rare disease oncology portfolio. Walgreens, now private under Sycamore Partners, is cutting 628 jobs and splitting into five standalone companies — Shields Health, CareCentrix, VillageMD, Boots, and the retail pharmacy. Financial sponsors are acquiring, restructuring, and separating healthcare assets at a pace that demands every practice owner understand who owns their supply chain, their lab, and their payer.

AI is crossing from pilot to P&L impact. Highmark Health generated $28M in measurable value from its Google Cloud AI assistant in 2025 — 6 million prompts across 74 active use cases, up from 31 the prior year. Isomorphic Labs raised $600 million for AI-driven drug discovery, with Eli Lilly and Novartis pledging nearly $3 billion to tap its AlphaFold technology. In dental, LightSpun partnered with Smile America Partners to use AI credentialing to accelerate provider enrollment for 500,000 underserved kids — cutting a 45-60 day process that wastes entire school terms while children wait for care. The organizations measuring AI ROI in dollars, not demos, are pulling away from everyone else.

Dental's ownership structure keeps evolving. Standard Dental Labs is building the first publicly traded dental lab roll-up (OTCQB: TUTH) — the DSO consolidation playbook applied to the lab side. Salt Dental Partners added practices in New York, Virginia, and California in February. Aria Care Partners acquired Sanford Dental, expanding its Southeast footprint. Henry Schein opened a dental-medical integration training center in Southlake, Texas, betting the wall between dental and medical practice is coming down — while Texas Tech launched an oral surgery residency backed by a $500,000 endowed professorship to address specialist pipeline gaps in the Southwest. The consolidation machine hasn't paused. It's shifted from announcement-driven growth to operational integration — and the supply chain (labs, training, credentialing) is now the target.

Meanwhile, 1,281 confirmed measles cases in 2026 through March 5 — 991 in South Carolina's Spartanburg County alone, 94% in unvaccinated individuals. Practices: screen vaccination status, update exposure protocols, and prepare for the liability questions that follow when public health messaging collapses. On the drug side, FDA approved a myeloma combination therapy showing 83% reduction in disease progression risk — cleared in 55 days under the Priority Voucher program, proving the agency can still move fast when the data is unambiguous.

Federal health infrastructure is hollowing out, states are scrambling to fill it, labor is striking, and private capital is restructuring the industry's ownership map — all while AI quietly crosses from experiment to enterprise value. The practices and systems that are measuring, adapting, and automating now will own the next five years. The rest will be acquired.

📈 Capital Pulse — Our weekly healthcare market review is live. Payers cratered on Elevance CMS sanctions, behavioral health and healthcare IT surged on earnings beats, and dental went risk-off. 28 tickers, 4 sectors, one sharp take.

📊 DSO Deal Tracker — 3,200+ dental & healthcare M&A transactions tracked since 2016. Filter by year, state, acquirer type, and sector. Updated daily.

Built by the team behind Praxis AI — intelligence for modern healthcare.